<DOC>
	<DOCNO>NCT00525590</DOCNO>
	<brief_summary>The purpose study determine effect surgical intervention insertion GLIADEL wafer neurocognitive functioning patient metastatic brain cancer .</brief_summary>
	<brief_title>Exploratory Study , Evaluating Treatment Effect Surgery Plus GLIADEL® Wafer Patients With Metastatic Brain Cancer</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>1 . Can provide signed/dated Informed Consent , Health Insurance Portability Accountability Act 1996 ( HIPAA ) authorization . 2 . Are male female patient 18 year age old . 3 . Are willing use barrier method contraception fertile childbearing potential 30 day surgical resection . If patient receives subsequent chemotherapy study participation ( allow protocol ) , appropriate contraception manage principal investigator . 4 . Have primary diagnosis solidbased tumor cancer ( except small cell lung cancer ( SCLS ) , lymphoma , germ cell cancer anaplastic thyroid cancer ) unknown primary cancer 13 brain metastasis ( e ) surgical resection plan single metastasis remain metastasis plan stereotactic radiosurgery ( SRS ) ; OR intraoperative diagnosis metastatic brain tumor patient single brain lesion . 5 . Have life expectancy ≥12 week . 6 . Have Karnofsky Performance Status ( KPS ) score 70 high . 7 . Have Recursive Partitioning Analysis ( RPA ) status 1 2 . 8 . Women childbearing potential must negative serum urine pregnancy test within 14 day surgical resection ; 9 . Patients must able understand English , either orally write , able consent complete require assessment procedure . 1 . Are unable unwilling understand study assessment cooperate study procedure determine investigator . 2 . Have history allergic reaction know hypersensitivity BCNU ( carmustine ) component GLIADEL , polifeprosan polymer . 3 . Have history prior cranial irradiation . 4 . Have prior diagnosis Central Nervous System ( CNS ) tumor . 5 . Have receive prior treatment brain tumor . 6 . Have prior exposure GLIADEL component , polifeprosan polymer . 7 . Have uncontrolled medical psychiatric condition preclude participate complete study procedure . 8 . Concurrent severe medical condition include , limited , active infection , acute hepatitis , cardiac arrhythmia , unstable angina , congestive heart failure , uncontrolled diabetes mellitus , uncontrolled seizure , pulmonary insufficiency , pulmonary fibrosis , pulmonary embolus , etc . 9 . Have diagnosis tumor brain stem posterior fossa . 10 . Have RPA status 3 . 11 . Have diagnosis leptomeningeal disease time enrollment ; 12 . Are currently pregnant lactating , plan become pregnant course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Gliadel</keyword>
</DOC>